Dhiraj Acharya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dhiraj Acharya has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- GuanQun Liu
Department of Microbiology & Immunology, McGill University, Montreal, Canada
4 shared publications - Michaela U. Gack
Florida Research and Innovation Center, Cleveland Clinic
4 shared publications Cindy Chiang
Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL 34987, USA
2 shared publications- Michiel van Gent
HerpesLabNL, Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands
2 shared publications - Zuberwasim Sayyad
Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, USA
2 shared publications - Bart N. Lambrecht
Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
1 shared publication
Latest Publications
- Open Access
- 4 April 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (14)
MDA5 ISGylation is crucial for immune signaling to control viral replication and pathogenesis
The posttranslational modification (PTM) of innate immune sensor proteins by ubiquitin or ubiquitin-like proteins is crucial for regulating antiviral host responses. The cytoplasmic dsRNA receptor melanoma differentiation-associated protein 5 (MDA5) undergoes several PTMs including ISGylation within its first caspase activation and recruitment domain (CARD), which promotes MDA5 signaling. However, the relevance of MDA5 ISGylation for antiviral immunity in an infected organism has been elusive. Here, we generated knock-in mice (MDA5 K23R/K43R ) in which the two major ISGylation sites, K23 and K43, in MDA5, were mutated. Primary cells derived from MDA5 K23R/K43R mice exhibited abrogated endogenous MDA5 ISGylation and an impaired ability of MDA5 to form oligomeric assemblies, leading to blunted cytokine responses to MDA5 RNA-agonist stimulation or infection with encephalomyocarditis virus (EMCV) or West Nile virus. Phenocopying MDA5 −/− mice, the MDA5 K23R/K43R mice infected with EMCV displayed increased myocardial injury and mortality, elevated viral titers, and an ablated induction of cytokines and chemokines compared to WT mice. Molecular studies identified human HERC5 (and its functional murine homolog HERC6) as the primary E3 ligases responsible for MDA5 ISGylation and activation. Taken together, these findings establish the importance of CARD ISGylation for MDA5-mediated RNA virus restriction, promoting potential avenues for immunomodulatory drug design for antiviral or anti-inflammatory applications.
- 4 April 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (14)
Open AccessMDA5 ISGylation is crucial for immune signaling to control viral replication and pathogenesis
The posttranslational modification (PTM) of innate immune sensor proteins by ubiquitin or ubiquitin-like proteins is crucial for regulating antiviral host responses. The cytoplasmic dsRNA receptor melanoma differentiation-associated protein 5 (MDA5) undergoes several PTMs including ISGylation within its first caspase activation and recruitment domain (CARD), which promotes MDA5 signaling. However, the relevance of MDA5 ISGylation for antiviral immunity in an infected organism has been elusive. Here, we generated knock-in mice (MDA5 K23R/K43R ) in which the two major ISGylation sites, K23 and K43, in MDA5, were mutated. Primary cells derived from MDA5 K23R/K43R mice exhibited abrogated endogenous MDA5 ISGylation and an impaired ability of MDA5 to form oligomeric assemblies, leading to blunted cytokine responses to MDA5 RNA-agonist stimulation or infection with encephalomyocarditis virus (EMCV) or West Nile virus. Phenocopying MDA5 −/− mice, the MDA5 K23R/K43R mice infected with EMCV displayed increased myocardial injury and mortality, elevated viral titers, and an ablated induction of cytokines and chemokines compared to WT mice. Molecular studies identified human HERC5 (and its functional murine homolog HERC6) as the primary E3 ligases responsible for MDA5 ISGylation and activation. Taken together, these findings establish the importance of CARD ISGylation for MDA5-mediated RNA virus restriction, promoting potential avenues for immunomodulatory drug design for antiviral or anti-inflammatory applications.
- 20 July 2023
- Published by Elsevier in Cell Host & Microbe
- Vol. 31 (8) , 1317-1330.e10
Acetylation of the NS3 helicase by KAT5γ is essential for flavivirus replication
- 20 July 2023
- Published by Elsevier in Cell Host & Microbe
- Vol. 31 (8) , 1317-1330.e10
Acetylation of the NS3 helicase by KAT5γ is essential for flavivirus replication
- 25 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (77) , eabq4531
GTF3A mutations predispose to herpes simplex encephalitis by disrupting biogenesis of the host-derived RIG-I ligand RNA5SP141
Herpes simplex virus 1 (HSV-1) infects several billion people worldwide and can cause life-threatening herpes simplex encephalitis (HSE) in some patients. Monogenic defects in components of the type I interferon system have been identified in patients with HSE, emphasizing the role of inborn errors of immunity underlying HSE pathogenesis. Here, we identify compound heterozygous loss-of-function mutations in the gene GTF3A encoding for transcription factor IIIA (TFIIIA), a component of the RNA polymerase III complex, in a patient with common variable immunodeficiency and HSE. Patient fibroblasts and GTF3A gene–edited cells displayed impaired HSV-1–induced innate immune responses and enhanced HSV-1 replication. Chromatin immunoprecipitation sequencing analysis identified the 5 S ribosomal RNA pseudogene 141 ( RNA5SP141 ), an endogenous ligand of the RNA sensor RIG-I, as a transcriptional target of TFIIIA. GTF3A mutant cells exhibited diminished RNA5SP141 expression and abrogated RIG-I activation upon HSV-1 infection. Our work unveils a crucial role for TFIIIA in transcriptional regulation of a cellular RIG-I agonist and shows that GTF3A genetic defects lead to impaired cell-intrinsic anti–HSV-1 responses and can predispose to HSE.
- 25 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (77) , eabq4531
GTF3A mutations predispose to herpes simplex encephalitis by disrupting biogenesis of the host-derived RIG-I ligand RNA5SP141
Herpes simplex virus 1 (HSV-1) infects several billion people worldwide and can cause life-threatening herpes simplex encephalitis (HSE) in some patients. Monogenic defects in components of the type I interferon system have been identified in patients with HSE, emphasizing the role of inborn errors of immunity underlying HSE pathogenesis. Here, we identify compound heterozygous loss-of-function mutations in the gene GTF3A encoding for transcription factor IIIA (TFIIIA), a component of the RNA polymerase III complex, in a patient with common variable immunodeficiency and HSE. Patient fibroblasts and GTF3A gene–edited cells displayed impaired HSV-1–induced innate immune responses and enhanced HSV-1 replication. Chromatin immunoprecipitation sequencing analysis identified the 5 S ribosomal RNA pseudogene 141 ( RNA5SP141 ), an endogenous ligand of the RNA sensor RIG-I, as a transcriptional target of TFIIIA. GTF3A mutant cells exhibited diminished RNA5SP141 expression and abrogated RIG-I activation upon HSV-1 infection. Our work unveils a crucial role for TFIIIA in transcriptional regulation of a cellular RIG-I agonist and shows that GTF3A genetic defects lead to impaired cell-intrinsic anti–HSV-1 responses and can predispose to HSE.
- 13 December 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (51)
Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23
Significance: Herpes simplex viruses (HSV) can switch between lytic and latent infections, which are lifelong sources of recurrent diseases. In this process, the immediate early protein ICP0 crucially drives herpesvirus gene expression or reactivation from latency. The regulatory network of ICP0 expression is, however, largely obscure. We uncover that the HSV-1 virulence factor γ 1 34.5 interacts with and stabilizes ICP0. We also demonstrate that TRIM23, a cellular E3 ligase, triggers proteasomal degradation of ICP0 in the absence of γ 1 34.5. As such, removal of γ 1 34.5 or ICP0 from HSV-1 cripples viral growth, whereas ablation of TRIM23 restores viral production. These findings provide a framework of virus–host regulatory circuits, which may help in the rational design of antiviral or oncolytic therapeutics.
- 13 December 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (51)
Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23
Significance: Herpes simplex viruses (HSV) can switch between lytic and latent infections, which are lifelong sources of recurrent diseases. In this process, the immediate early protein ICP0 crucially drives herpesvirus gene expression or reactivation from latency. The regulatory network of ICP0 expression is, however, largely obscure. We uncover that the HSV-1 virulence factor γ 1 34.5 interacts with and stabilizes ICP0. We also demonstrate that TRIM23, a cellular E3 ligase, triggers proteasomal degradation of ICP0 in the absence of γ 1 34.5. As such, removal of γ 1 34.5 or ICP0 from HSV-1 cripples viral growth, whereas ablation of TRIM23 restores viral production. These findings provide a framework of virus–host regulatory circuits, which may help in the rational design of antiviral or oncolytic therapeutics.
- Open Access
ISG15-dependent Activation of the RNA Sensor MDA5 and its Antagonism by the SARS-CoV-2 papain-like protease
Activation of the RIG-I-like receptors, RIG-I and MDA5, establishes an antiviral state by upregulating interferon (IFN)-stimulated genes (ISGs). Among these is ISG15 whose mechanistic roles in innate immunity still remain enigmatic. Here we report that ISGylation is essential for antiviral IFN responses mediated by the viral RNA sensor MDA5. ISG15 conjugation to the caspase activation and recruitment domains of MDA5 promotes the formation of higher-order assemblies of MDA5 and thereby triggers activation of innate immunity against a range of viruses including coronaviruses, flaviviruses and picornaviruses. The ISG15-dependent activation of MDA5 is antagonized through direct de-ISGylation mediated by the papain-like protease (PLpro) of SARS-CoV-2, a recently emerged coronavirus that causes the COVID-19 pandemic. Our work demonstrates a crucial role for ISG15 in the MDA5-mediated antiviral response, and also identifies a novel immune evasion mechanism of SARS-CoV-2, which may be targeted for the development of new antivirals and vaccines to combat COVID-19.
Open AccessISG15-dependent Activation of the RNA Sensor MDA5 and its Antagonism by the SARS-CoV-2 papain-like protease
Activation of the RIG-I-like receptors, RIG-I and MDA5, establishes an antiviral state by upregulating interferon (IFN)-stimulated genes (ISGs). Among these is ISG15 whose mechanistic roles in innate immunity still remain enigmatic. Here we report that ISGylation is essential for antiviral IFN responses mediated by the viral RNA sensor MDA5. ISG15 conjugation to the caspase activation and recruitment domains of MDA5 promotes the formation of higher-order assemblies of MDA5 and thereby triggers activation of innate immunity against a range of viruses including coronaviruses, flaviviruses and picornaviruses. The ISG15-dependent activation of MDA5 is antagonized through direct de-ISGylation mediated by the papain-like protease (PLpro) of SARS-CoV-2, a recently emerged coronavirus that causes the COVID-19 pandemic. Our work demonstrates a crucial role for ISG15 in the MDA5-mediated antiviral response, and also identifies a novel immune evasion mechanism of SARS-CoV-2, which may be targeted for the development of new antivirals and vaccines to combat COVID-19.